Human invariant Vα24-JαQ TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice

Journal of Immunology

Volumn 170, Issue 5, 2003, Pages 2390-2398

  Capone, Myriam ^a,e   Cantarella, Daniela ^b   Schümann, Jens ^a   Naidenko, Olga V ^c,f   Garavaglia, Claudio ^b   Beermann, Friederich ^d   Kronenberg, Mitchell ^c   Dellabona, Paolo ^b   MacDonald, H R ^a,h   Casorati, Giulia ^b,g  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b H San Raffaeie Scientific Institute   (Italy)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^d SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^e CNRS Bordeaux Segalen University   (France)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g DIBIT   (Italy)

^h LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; T LYMPHOCYTE RECEPTOR; TETRAMER;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; GENE REARRANGEMENT; HOMEOSTASIS; LIVER; LYMPHOCYTE DIFFERENTIATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 0344211821     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.5.2390     Document Type: Article

References (45)

1. + cells: new clues to their origin, specificity, and function. J. Exp. Med. 182:633.
2. Bendelac, A., M. N. Rivera, S. H. Park, and J. H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535.
3. Kronenberg, M., and L. Gapin. 2002. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2:557.
4. - α/β T cells demonstrates preferential use of several Vβ genes and an invariant TCRα-chain. J. Exp. Med. 178:1,
5. - T cells in mice and humans. J. Exp. Med. 180:1097.
6. - T cells. J. Exp. Med. 180:1171.
7. + cells in mouse liver. J. Exp. Med. 183:1277.
8. Matsuda, J. L., L. Gapin, N. Fazilleau, K. Warren, O. V. Naidenko, and M. Kronenberg. 2001. Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor β repertoire and small clone size. Proc. Natl. Acad. Sci. USA 98:12636.
9. MacDonald, H. R. 2002. Development and selection of NKT cells. Curr. Opin. Immunol. 14:250.
10. Eberl, G., R. Lees, S. T. Smiley, M. Taniguchi, M. J. Grusby, and H. R. MacDonald. 1999. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J. Immunol. 162:6410.
11. Godfrey, D. I., K. J. Hammond, L. D. Poulton, M. J. Smyth, and A. G. Baxter. 2000. NKT cells: facts, functions, and fallacies. Immunol. Today 21:573.
12. Hong, S., M. T. Wilson, I. Serizawa, L. Wu. N. Singh. O. V. Naidenko, T. Miura, T. Haba, D. C. Scherer, J. Wei, et al. 2001. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in nonobese diabetic mice. Nat. Med. 7:1052.
13. Sharif, S., G. A. Arreaza, P. Zucker, Q. S. Mi, J. Sondhi, O. V. Naidenko, M. Kronenberg, Y. Koezuka, T. L. Delovitch, J. M. Gombert, et al. 2001. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat. Med. 7:1057.
14. Singh, A. K., M. T. Wilson, S. Hong, D. Olivares-Villagomez, C. Du, A. K. Stanic, S. Joyce, S. Sriram, Y. Koezuka, and L. Van Kaer. 2001. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 194:1801.
15. Gonzalez-Aseguinolaza, G., L. Van Kaer, C. C. Bergmann, J. M. Wilson, J. Schmieg, M. Kronenberg, T. Nakayama, M. Taniguchi, Y. Koezuka, and M. Tsuji. 2002. Natural killer T cell ligand α-galactosylceramide enhances protective immunity induced by malaria vaccines. J. Exp. Med. 195:617.
16. Cui, J. Q., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Vα14 Nkt cells in II-12-mediated rejection of tumors. Science 278:1623.
17. Toura, I., T. Kawano, Y. Akutsu, T. Nakayama, T. Ochiai, and M. Taniguchi. 1999. Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with α-galactosylceramide. J. Immunol. 163:2387.
18. + T lymphocytes. Science 268:863.
19. - T cells. J. Exp. Med. 186:109.
20. Brossay, L., M. Chioda, N. Burdin, Y. Koezuka, G. Casorati. P. Dellabona, and M. Kronenberg. 1998. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J, Exp. Med. 188:1521.
21. Zeng, Z., A. R. Castano, B. W. Segelke, E. A. Stura, P. A. Peterson, and I. A. Wilson. 1997. Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 277:339.
22. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, H. Koseki, and M. Taniguchi. 1997. CD1drestricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278:1626.
23. + NK T lymphocytes. J. Immunol. 161:3271.
24. Spada, F. M., Y. Koezuka, and S. A. Porcelli. 1998. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med. 188:1529.
25. - subset. J. Exp. Med. 177:1763.
26. Zhumabekov, T., P. Corbella, M. Tolaini, and D. Kioussis. 1995. Improved version of a human CD2 minigene-based vector for T cell-specific expression in transgenic mice. J. Immunol. Methods 185:133.
27. Philpott, K. L., J. L. Viney, G. Kay, S. Rastan, E. M. Gardiner, S. Chae, A. C. Hayday, and M. J. Owen. 1992. Lymphoid development in mice congenitally lacking T cell receptor αβ-expressing cells. Science 256:1448.
28. Matsuda, J. L., O. V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C. R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192:741.
29. Wack, A., D. Montagna, P. Dellabona, and G. Casorati. 1996. An improved PCR-heteroduplex method permits high-sensitivity detection of clonal expansions in complex T cell populations. J. Immunol. Methods 196:181.
30. Davodeau, F., M. A. Peyrat, A. Necker, R. Dominici, F. Blanchard, C. Leget, J. Gaschet, P. Costa, Y. Jacques, A. Godard, et al. 1997. Close phenotypic and functional similarities between human and murine αβ T cells expressing invariant TCR α-chains. J. Immunol. 158:5603.
31. Bendelac, A., R. D. Hunziker, and O. Lantz. 1996. Increased interleulkin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells, J. Exp. Med. 184:1285.
32. Brabb, T., R. Rubicz, V. Mannikko, and J. Goverman. 1997. Separately expressed T cell receptor α- and β-chain transgenes exert opposite effects on T cell differentiation and neoplastic transformation. Eur. J. Immunol. 27:3039.
33. Lacorazza, H. D., C. Tuek-Szabo, L. V. Vasovic, K. Remus, and J. Nikolich-Zugich. 2001. Premature TCR αβ expression and signaling in early thymocytes impair thymocyte expansion and partially block their development. J. Immunol. 166:3184.
34. Gapin, L., J. L. Matsuda, C. D. Surh, and M. Kronenberg. 2001. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immun. 10:10.
35. Benlagha, K., T. Kyin, A. Beavis, L. Teyton, and A. Bendelac. 2002. A thymic precursor to the NK T cell lineage. Science 296:553.
36. - CDd-dependent precursor stage. J. Exp. Med. 195:835.
37. MacDonald, H. R. 2002. Immunology: T before NK. Science 296:481.
38. Benlagha, K., A. Weiss, A. Beavis. L. Teyton, and A. Bendelac. 2000. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191:1895.
39. Lehuen, A., O. Lantz, L. Beaudoin, V. Laloux, C. Carnaud, A. Bendelac, J.-F. Bach, and R. C. Monteiro. 1998. Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188:1831.
40. Laloux, V., L. Beaudoin, D. Jeske, C. Carnaud, and A. Lehuen. 2001. NK T cell-induced protection against diabetes in Vα14-Jα281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen. J. Immunol. 166:3749.
41. + T cells with a transgenic variant TCR. J. Immunol. 165:168.
42. + T lymphocytes. J. Immunol. 168:5514.
43. Clark, S. P., B. Arden, D. Kabelitz, and T. W. Mak. 1995. Comparison of human and mouse T-cell receptor variable gene segment subfamilies. Immunogenetics 42:531.
44. Gumperz, J. E., C. Roy, A. Makowska, D. Lum, M. Sugita, T. Podrebarac, Y. Koezuka, S. A. Porcelli. S. Cardell, M. B. Brenner, and S. M. Behar. 2000. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12:211.
45. + cells. J. Immunol. 164:2412.